Pharmacology of Antiamoebic and Antiprotozoal Drugs

Introduction/Overview The pharmacological management of protozoal infections represents a critical component of global infectious disease therapy. Protozoal parasites, including amoebae, plasmodia, leishmania, and trypanosomes, are responsible for significant morbidity and mortality worldwide, particularly in tropical and subtropical regions and among immunocompromised populations. These eukaryotic pathogens present unique therapeutic challenges due to their complex life cycles, … Read more

Pharmacology of Antiamoebic and Antiprotozoal Drugs

Introduction/Overview The pharmacological management of infections caused by protozoan parasites represents a critical component of global infectious disease therapeutics. These infections, which include amoebiasis, malaria, leishmaniasis, trypanosomiasis, and giardiasis, contribute significantly to global morbidity and mortality, particularly in tropical and subtropical regions and among immunocompromised populations. The therapeutic arsenal against these pathogens is diverse, targeting … Read more

Pharmacology of Heavy Metals (Lead, Mercury, Arsenic)

Introduction/Overview The pharmacology of heavy metals represents a critical intersection of toxicology and therapeutics. Unlike conventional pharmaceuticals, lead, mercury, and arsenic are not administered for therapeutic benefit but are encountered as environmental and occupational toxicants. Their study is essential due to their pervasive presence, capacity for bioaccumulation, and potent disruption of fundamental cellular processes. Understanding … Read more

Pharmacology of Antimalarial Drugs

Introduction/Overview Malaria remains a significant global health challenge, with an estimated 247 million cases and 619,000 deaths reported in 2021, predominantly affecting children under five years of age in sub-Saharan Africa. The pharmacology of antimalarial drugs constitutes a critical domain of study, integrating parasitology, chemotherapy, and clinical medicine. These agents target protozoan parasites of the … Read more

Pharmacology of Ophthalmic Agents

1. Introduction/Overview The pharmacology of ophthalmic agents encompasses the study of drugs used for the diagnosis and treatment of ocular diseases. This specialized field integrates principles of general pharmacology with the unique anatomical and physiological constraints of the eye. The eye presents a series of formidable barriers to drug delivery, including the cornea, conjunctiva, and … Read more

Pharmacology of Antiretroviral Drugs (HIV)

Introduction/Overview The management of human immunodeficiency virus (HIV) infection represents one of the most significant achievements in modern therapeutics. The development of antiretroviral drugs has transformed HIV from a uniformly fatal diagnosis to a manageable chronic condition. The pharmacology of these agents is complex, involving multiple drug classes that target distinct stages of the viral … Read more

Pharmacology of Antiretroviral Drugs (HIV)

Introduction/Overview The management of human immunodeficiency virus (HIV) infection represents one of the most significant achievements in modern therapeutics. The development of antiretroviral drugs has transformed HIV from a uniformly fatal diagnosis to a manageable chronic condition. The pharmacology of these agents is complex, involving multiple drug classes that target distinct stages of the viral … Read more

Pharmacology of Antiviral Drugs

1. Introduction/Overview The development of effective antiviral agents represents a cornerstone of modern therapeutics, fundamentally altering the management of numerous viral infections. Unlike antibacterial drugs, which target numerous unique bacterial structures and metabolic pathways, antiviral drugs must selectively inhibit processes that are essential for viral replication yet distinct enough from host cell functions to ensure … Read more

Pharmacology of Antiviral Drugs

Introduction/Overview The development and clinical application of antiviral drugs represent a cornerstone of modern therapeutics, fundamentally altering the management of viral infections that were once considered untreatable. Unlike antibacterial agents, antivirals target unique components of the viral life cycle without significantly affecting host cellular processes, presenting distinct pharmacological challenges. The clinical relevance of these agents … Read more

Pharmacology of Antifungal Drugs

Introduction/Overview The management of fungal infections represents a significant and growing challenge in clinical medicine. The increasing prevalence of invasive mycoses is closely associated with the expansion of immunocompromised patient populations, including those undergoing chemotherapy, organ transplantation, or living with HIV/AIDS, as well as the widespread use of broad-spectrum antibiotics and invasive medical devices. Fungal … Read more